MARKET

ARWR

ARWR

Arrowhead Pharma
NASDAQ
15.28
+1.31
+9.38%
After Hours: 15.45 +0.17 +1.11% 19:56 05/13 EDT
OPEN
15.75
PREV CLOSE
13.97
HIGH
16.83
LOW
14.77
VOLUME
4.49M
TURNOVER
--
52 WEEK HIGH
30.41
52 WEEK LOW
9.57
MARKET CAP
2.10B
P/E (TTM)
-2.9674
1D
5D
1M
3M
1Y
5Y
1D
Arrowhead Pharmaceuticals Price Target Cut to $17.00/Share From $21.00 by Citigroup
Dow Jones · 7h ago
Arrowhead Pharmaceuticals Is Maintained at Neutral by Citigroup
Dow Jones · 7h ago
Citigroup Maintains Neutral on Arrowhead Pharma, Lowers Price Target to $17
Benzinga · 7h ago
Archer Aviation Posts Narrower-Than-Expected Loss, Joins Microvast, Intuitive Machines And Other Big Stocks Moving Higher On Tuesday
Benzinga · 11h ago
Arrowhead Shares Rise After 2Q Earnings Beat
Dow Jones · 12h ago
Arrowhead Pharmaceuticals Price Target Maintained With a $60.00/Share by Chardan Capital
Dow Jones · 15h ago
Arrowhead Pharmaceuticals Is Maintained at Buy by Chardan Capital
Dow Jones · 15h ago
Chardan Capital Maintains Buy on Arrowhead Pharma, Maintains $60 Price Target
Benzinga · 15h ago
More
About ARWR
More
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. It has around 14 clinical-stage investigational medicines (nine wholly owned and five partnered), which range in development stage from Phase I to Phase III. The Company's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MUC5AC, ARO-MMP7, GSK-4532990, Fazirsiran, JNJ-3989, HZN-457, ARO-C3, ARO-PNPLA3, ARO-DUX4 and ARO-SOD1.
Recently
Symbol
Price
%Change

Webull offers Arrowhead Pharmaceuticals Inc stock information, including NASDAQ: ARWR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARWR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARWR stock methods without spending real money on the virtual paper trading platform.